Targeting SLC6A8 suppresses tumor growth and enhances ferroptosis in hepatocellular carcinoma
Abstract Background Hepatocellular carcinoma (HCC) persists as a therapeutic challenge owing to restricted treatment alternatives and the dearth of effective biomarkers. The creatine transporter SLC6A8 has been documented to participate in the progression of various malignancies. However, the role t...
Na minha lista:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer
2026-03-01
|
| coleção: | Journal of Cancer Research and Clinical Oncology |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1007/s00432-026-06442-8 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|